Home > Education Hub > We Announce our role as Strategic Advisor to Mérieux Equity Partners and Mérieux Participations 3 for Entering the Capital of CTRS

We Announce our role as Strategic Advisor to Mérieux Equity Partners and Mérieux Participations 3 for Entering the Capital of CTRS

News

Category:

M&A Pharma

Published on:

December 20, 2020

Alira Health is pleased to announce its role as strategic advisor to Mérieux Equity Partners as they join the Series A financing round of Cell-Easy, through Mérieux’s newly established venture fund, OMX.

Merieux Equity Partners is a global asset manager specialized in the healthcare and nutrition sectors. Cell-Easy is a novel French pharmaceutical laboratory specialized in the development and manufacturing of novel cell therapies for preclinical and clinical studies. This fund raising aims at accelerating the company’s growth in France and internationally, by expanding the Cell-Easy Management Team and strengthening the company’s commercial presence in key regions.

To read the press release on BusinessWire, click here.

For more information, contact Joris Pezzini.

For more information about Alira Health Transaction Advisory services

Click here

Related news

Due Diligence Pharma

News July 21, 2021

Alira Health Announces its Role as Strategic Advisor to Naxicap

Alira Health is proud to announce its role as strategic advisor to Naxicap in the equity investment in Ceres Pharma Bv.

Events June 30, 2021

Event: Bio Asia-Taiwan

Join Daniela Sica, Vice President, Business Development, Pharma & Biotech, and Shu-Ling Cheng, Partner, at Biotechnology Innovation Organization's Bio-Asia Taiwan July 21-25, 2021.

Due Diligence MedTech Patient Engagement Pharma

Multimedia April 12, 2021

Evolution of the Drug Delivery Systems Industry and its Increasing Role in Driving Patient Outcomes

In the third episode, Amira Ghozali, Aptar Pharma, Kenny Carberry, and Aude Ouensanga, discuss the evolution of the DDS industry, its relationship with Pharma, and its increasing role(...)

M&A MedTech Pharma

News April 12, 2021

Alira Health Strengthens its Growth Strategy with a $35M Funding, led by Creadev

Alira Health strengthens its growth strategy with a $35M funding, led by Creadev.

Publications February 24, 2021

What You Should Know Before Choosing a Healthcare Transaction Advisory Firm

What’s most important when selecting a firm for your next transaction? Global experience, staff profiles, technical expertise? To learn more download our latest TAD Infographic.

Publications February 8, 2021

Infographic: 2021 Trends in Healthcare

It is no secret that the COVID-19 pandemic has presented new challenges for businesses, and virtual has become the ‘new normal’, including for transactions.

News February 4, 2021

2020 Year in Review

With 2021 in full swing, we want to take a moment to reflect on last year’s achievements and congratulate the entire Alira Health Team for their hard work and dedication to healthcare(...)

Our locations around the globe

USA, Boston

1 Grant Street, Suite 400, Framingham, Boston,
MA 01702, USA
+1 (774) 777 5255

USA, North Carolina

1340 Environ Way, 3rd Floor,
Chapel Hill,
NC 27517, USA
+1 919-929-5015
+1 919-928-9320

USA, San Francisco

San Francisco,
CA 94108, USA
+1 (774) 777 5255

France, Paris

12 Rue Charlot
75003 Paris, France
+33 (0)9 72 16 55 57

Germany, Munich

Kurfürstenstraße 22
80801 Munich, Germany
+49 (89) 416 14 22-0

Italy, Verona

Via Germania 2
37136 Verona, Italy
+39 045 820 26 66
+39 045 820 58 75

Italy, Bologna

Galleria Guglielmo Marconi 2
(all’altezza di Via Guglielmo Marconi 29)
40122 Bologna, Italy

Italy, Milan

Via Carlo Ottavio
Cornaggia 10
20123 Milan, Italy

Spain, Barcelona

Carrer de Balmes, 206 – Ático 2 08006 Barcelona, Spain
+34 (0)93 737 65 70

UK, Milton Keynes

Fairbourne Drive,
Atterbury Lakes,
Milton Keynes,
MK10 9RG, United Kingdom
+44 (0)1908 488787

Switzerland, Geneva

Campus Biotech Innovation Park
Avenue de Sécheron 15
1202 Geneva, Switzerland
+41 (0)61 205 9669

Switzerland, Basel

Badenstrasse 3
4057 Basel, Switzerland
+41 (0)61 205 9669

Contact us